Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Damnacanthal possesses anti-cancer, immunomodulatory, antinociceptive and anti-inflammatory actions, it can treat or prevent hepatocellular carcinoma through its inhibitory effects on the HGF/c-Met axis.
説明 | Damnacanthal possesses anti-cancer, immunomodulatory, antinociceptive and anti-inflammatory actions, it can treat or prevent hepatocellular carcinoma through its inhibitory effects on the HGF/c-Met axis. |
ターゲット&IC50 | p56lck autophosphorylation:46 nM (IC50), Phosphorylation of exogenous substrates by p56lck:220 nM (IC50) |
In vitro | Here we show that Damnacanthal has profound inhibitory activity on mast cell activation through this pathway. The release of the granule compounds beta-hexosaminidase and tryptase release was completely abrogated by Damnacanthal at doses that were non-toxic to mast cells. In addition, Damnacanthal inhibited activation-dependent pro-inflammatory gene induction, as well as cytokine/chemokine release in response to mast cell stimulation. The mechanism underlying Damnacanthal inhibition was linked to impaired phosphorylation of Syk and Akt. Furthermore, Damnacanthal inhibited mast cell activation in response to calcium ionophore A23187[1] |
植物由来 |
分子量 | 282.25 |
分子式 | C16H10O5 |
CAS No. | 477-84-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Damnacanthal 477-84-9 Angiogenesis Cytoskeletal Signaling Immunology/Inflammation PI3K/Akt/mTOR signaling Tyrosine Kinase/Adaptors IL Receptor Akt Syk Inhibitor inhibitor inhibit